• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHOCKWAVE MEDICAL, INC. SHOCKWAVE C2+ CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHOCKWAVE MEDICAL, INC. SHOCKWAVE C2+ CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER Back to Search Results
Model Number C2PIVL4012
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Myocardial Infarction (1969)
Date of Event 12/11/2023
Type of Reportable Event Serious Injury
Event or Problem Description
This event was reported to shockwave via the post market empower cad clinical study.A shockwave c2+ coronary intravascular lithotripsy (ivl) catheter was used to treat a lesion in the mid right coronary artery (rca).10 pulses were successfully delivered at a max of 6 atm.There was no ivl malfunction reported.Prior to the procedure, the patient's creatine kinase-mb (ck-mb) was measured at normal baseline level.Within forty-eight (48) hours after the procedure, the patient's cm-mb levels became elevated to 100 times the upper normal limit (uln).The patient was discharged.This event was adjudicated by the clinical events committee (cec) which confirmed a non q-wave myocardial infarction was attributable to the target vessel.The cec noted loss of side branches in the rca as well as st elevation in inferior leads post-index procedure.It was determined that the mi was possibly related to the study device and definitely related to the procedure.
 
Additional Manufacturer Narrative
The device referenced in this report was not returned to shockwave medical, inc.Therefore, a physical examination cannot be performed.The root cause of the myocardial infarction could not be definitively determined based on the information available.There was no ivl malfunction reported.The cec determined that the mi was possibly related to the study device and definitely related to the procedure.Shockwave medical has controls in place to ensure devices are built to approved procedures and meet lot release acceptance criteria prior to being distributed.A review of the manufacturing and test documentation for subject lot does not reveal any issues with the manufacturing of the device.The device passed all of shockwave medical, inc.Acceptance criteria prior to shipping.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHOCKWAVE C2+ CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER
Common Device Name
SHOCKWAVE C2+ CORONARY INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER
Manufacturer (Section D)
SHOCKWAVE MEDICAL, INC.
5403 betsy ross drive
santa clara 95054
Manufacturer (Section G)
SHOCKWAVE MEDICAL, INC
5403 besty ross drive
santa clara CA 95054
Manufacturer Contact
alexis weil
5403 betsy ross drive
santa clara 95054
MDR Report Key21330059
Report Number3015053858-2025-00015
Device Sequence Number12935804
Product Code QMG
UDI-Device Identifier00195451000034
UDI-Public(01)00195451000034(17)250731(10)04A230714A
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P200039/S008
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/06/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/31/2025
Device Model NumberC2PIVL4012
Device Catalogue NumberC2PIVL4012
Device Lot Number04A230714A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/09/2025
Initial Report FDA Received Date02/07/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/14/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DRUG ELUDING STENT - MEDTRONIC ONYX FRONTIER; NON-COMPLIANT BALLOON FOR POST-DILATATION - SPRINT; NON-COMPLIANT BALLOON FOR PRE-DILATATION - EUPHORA
Outcome Attributed to Adverse Event Other;
Patient Age83 YR
Patient SexFemale
Patient EthnicityNon Hispanic
-
-